The FDA released a Declaratory Order on December 19th re-evaluating and essentially re-instituting its previous position on the tirzepatide shortage, declaring the shortage resolved. As a bit of ...
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug. HealthDay News — Pharmacists may continue making ...
Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care. The ...
Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy and ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has notched ...
Hosted on MSN
Novo Nordisk Wins Another Legal Battle Against Compounding Of Wegovy, Ozempic: Retail’s Bullish
Novo Nordisk (NVO) announced on Friday that it has secured a legal victory against compounders selling unauthorized versions of the company’s Wegovy and Ozempic drugs. A Texas federal court denied a ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and Zepbound has filed a lawsuit against the Food and Drug Administration (FDA) ...
As the contentious debate over compounded weight loss drugs continues, Eli Lilly is stepping out with an ad campaign to further stake its claim as a leader in the obesity market. In the national print ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results